GB2384986B - Compositions for the treatment of disorders of the upper gastrointestinal tract - Google Patents

Compositions for the treatment of disorders of the upper gastrointestinal tract

Info

Publication number
GB2384986B
GB2384986B GB0203269A GB0203269A GB2384986B GB 2384986 B GB2384986 B GB 2384986B GB 0203269 A GB0203269 A GB 0203269A GB 0203269 A GB0203269 A GB 0203269A GB 2384986 B GB2384986 B GB 2384986B
Authority
GB
United Kingdom
Prior art keywords
disorders
compositions
treatment
gastrointestinal tract
upper gastrointestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0203269A
Other languages
English (en)
Other versions
GB2384986A (en
GB0203269D0 (en
Inventor
Sophie Eugenie Axford
Paul Andrew Dickson
Ian Gordon Jolliffe
Paul Marshall
Rolf Myrvold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Priority to GB0203269A priority Critical patent/GB2384986B/en
Publication of GB0203269D0 publication Critical patent/GB0203269D0/en
Priority to JP2003567427A priority patent/JP4276545B2/ja
Priority to RU2004127245/15A priority patent/RU2317087C2/ru
Priority to DE60300862T priority patent/DE60300862T2/de
Priority to AT03702746T priority patent/ATE297742T1/de
Priority to US10/502,863 priority patent/US20050069583A1/en
Priority to PCT/GB2003/000593 priority patent/WO2003068246A2/en
Priority to AU2003205868A priority patent/AU2003205868B2/en
Priority to ES03702746T priority patent/ES2242939T3/es
Priority to EP03702746A priority patent/EP1474154B1/en
Priority to CNB038036762A priority patent/CN1315483C/zh
Priority to KR1020047012429A priority patent/KR100976071B1/ko
Priority to PT03702746T priority patent/PT1474154E/pt
Priority to PL370141A priority patent/PL210931B1/pl
Priority to CA2474520A priority patent/CA2474520C/en
Priority to MXPA04007779A priority patent/MXPA04007779A/es
Publication of GB2384986A publication Critical patent/GB2384986A/en
Application granted granted Critical
Publication of GB2384986B publication Critical patent/GB2384986B/en
Priority to ZA200405848A priority patent/ZA200405848B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
GB0203269A 2002-02-12 2002-02-12 Compositions for the treatment of disorders of the upper gastrointestinal tract Expired - Fee Related GB2384986B (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB0203269A GB2384986B (en) 2002-02-12 2002-02-12 Compositions for the treatment of disorders of the upper gastrointestinal tract
CNB038036762A CN1315483C (zh) 2002-02-12 2003-02-07 组合物内在或相关的改进
PT03702746T PT1474154E (pt) 2002-02-12 2003-02-07 Melhorias em composicoes ou relacionadas com elas
DE60300862T DE60300862T2 (de) 2002-02-12 2003-02-07 Verbesserungen an oder in bezug auf arzneizusammensetzungen
AT03702746T ATE297742T1 (de) 2002-02-12 2003-02-07 Verbesserungen an oder in bezug auf arzneizusammensetzungen
US10/502,863 US20050069583A1 (en) 2002-02-12 2003-02-07 Compositions
PCT/GB2003/000593 WO2003068246A2 (en) 2002-02-12 2003-02-07 Improvements in or relating to compositions
AU2003205868A AU2003205868B2 (en) 2002-02-12 2003-02-07 Improvements in or relating to compositions
ES03702746T ES2242939T3 (es) 2002-02-12 2003-02-07 Mejoras a composiciones o relacionadas con las mismas.
EP03702746A EP1474154B1 (en) 2002-02-12 2003-02-07 Improvements in or relating to compositions
JP2003567427A JP4276545B2 (ja) 2002-02-12 2003-02-07 改良組成物
KR1020047012429A KR100976071B1 (ko) 2002-02-12 2003-02-07 조성물 내에서의 또는 조성물에 관련된 개선책
RU2004127245/15A RU2317087C2 (ru) 2002-02-12 2003-02-07 Улучшенные композиции и улучшения, связанные с композициями
PL370141A PL210931B1 (pl) 2002-02-12 2003-02-07 Kompozycja w postaci stałej nadająca się do połykania zawierająca alginian, wodorowęglan i/lub węglan, jej zastosowanie oraz sposób wytwarzania
CA2474520A CA2474520C (en) 2002-02-12 2003-02-07 Solid alginate compositions for use in treating gastric disorders
MXPA04007779A MXPA04007779A (es) 2002-02-12 2003-02-07 Mejoramiento en o relacionado a composiciones.
ZA200405848A ZA200405848B (en) 2002-02-12 2004-07-22 Improvements in or relating to compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0203269A GB2384986B (en) 2002-02-12 2002-02-12 Compositions for the treatment of disorders of the upper gastrointestinal tract

Publications (3)

Publication Number Publication Date
GB0203269D0 GB0203269D0 (en) 2002-03-27
GB2384986A GB2384986A (en) 2003-08-13
GB2384986B true GB2384986B (en) 2004-01-07

Family

ID=9930901

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203269A Expired - Fee Related GB2384986B (en) 2002-02-12 2002-02-12 Compositions for the treatment of disorders of the upper gastrointestinal tract

Country Status (17)

Country Link
US (1) US20050069583A1 (https=)
EP (1) EP1474154B1 (https=)
JP (1) JP4276545B2 (https=)
KR (1) KR100976071B1 (https=)
CN (1) CN1315483C (https=)
AT (1) ATE297742T1 (https=)
AU (1) AU2003205868B2 (https=)
CA (1) CA2474520C (https=)
DE (1) DE60300862T2 (https=)
ES (1) ES2242939T3 (https=)
GB (1) GB2384986B (https=)
MX (1) MXPA04007779A (https=)
PL (1) PL210931B1 (https=)
PT (1) PT1474154E (https=)
RU (1) RU2317087C2 (https=)
WO (1) WO2003068246A2 (https=)
ZA (1) ZA200405848B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
JP2006342085A (ja) * 2005-06-08 2006-12-21 Kao Corp Ｇｉｐ分泌抑制剤
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
EP1859786A1 (en) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
KR100919508B1 (ko) * 2007-08-14 2009-09-28 강원대학교산학협력단 매트릭스에 칼슘 카보네이트를 함유한 알지네이트 입자 및그 제조방법
GB0814376D0 (en) * 2008-08-06 2008-09-10 Reckitt Benckiser Healthcare Formulation
WO2010092468A1 (en) * 2009-02-13 2010-08-19 Carlo Ghisalberti Composition comprising alginates and d-limonene to treat gerd and dyspepsia
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
JP5909851B2 (ja) * 2010-02-24 2016-04-27 大正製薬株式会社 易嚥下性錠剤
KR20130091250A (ko) * 2010-04-23 2013-08-16 에스-바이오텍 홀딩 에이피에스 위산 중화용 고체 약학 조성물
KR101307293B1 (ko) * 2011-05-24 2013-09-26 주식회사 인트로팜텍 알긴산 화합물을 포함하는 과립형 약학 조성물, 및 이의 제조방법
LT2806880T (lt) 2012-01-27 2017-08-25 Institute Of Bioorganic Chemistry Farmacinė kompozicija, kaip substancija antacidiniam vaistui nuo refliukso
FR3068039B1 (fr) 2017-06-22 2020-07-10 Jellynov Composition auto-moussante en milieu acide et procede de preparation
CN110945063B (zh) 2017-07-20 2022-08-16 索尔维公司 作为发泡剂的官能化的微粒碳酸氢盐、含有其的可发泡聚合物组合物及其在制造热塑性发泡聚合物中的用途
IT201800002625A1 (it) * 2018-02-13 2019-08-13 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
IL312094A (en) * 2018-03-02 2024-06-01 Pharagen Llc Formulations treating acid reflux comprising sodium alginate
MX2024007707A (es) 2021-12-22 2024-07-01 Chemo Res S L Producto de goma de mascar antiacida que no se traga, procedimiento para su preparacion y usos del mismo.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
DE3580384D1 (de) * 1984-04-09 1990-12-13 Toyo Boseki Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
US4818518A (en) * 1984-11-16 1989-04-04 Uop Effervescent dentifrice
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
US5922351A (en) * 1991-03-27 1999-07-13 Bayer Corporation Lubricants for use in tabletting
HU213203B (en) * 1991-04-04 1997-03-28 Procter & Gamble Process for producing of ingestible pharmaceutical compositions comprising 3-(i-menthoxy)-propane-1,2-diol for treating upper gastrointestinal tract symptoms
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5908636A (en) * 1996-06-28 1999-06-01 Mcneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
US6395307B1 (en) * 1997-04-30 2002-05-28 Reckitt Benckiser (Uk) Limited Pourable alginate compositions
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EPODOC Abstract of BG 103124 A (BALKANFARMA DUPNITSA AD) see abstract. *

Also Published As

Publication number Publication date
GB2384986A (en) 2003-08-13
DE60300862D1 (de) 2005-07-21
MXPA04007779A (es) 2004-10-15
GB0203269D0 (en) 2002-03-27
WO2003068246A2 (en) 2003-08-21
JP2005517037A (ja) 2005-06-09
PT1474154E (pt) 2005-10-31
DE60300862T2 (de) 2006-05-11
JP4276545B2 (ja) 2009-06-10
CN1630523A (zh) 2005-06-22
AU2003205868A1 (en) 2003-09-04
RU2004127245A (ru) 2005-04-10
ES2242939T3 (es) 2005-11-16
KR100976071B1 (ko) 2010-08-17
AU2003205868B2 (en) 2007-05-17
EP1474154B1 (en) 2005-06-15
PL210931B1 (pl) 2012-03-30
WO2003068246A3 (en) 2003-12-18
CA2474520C (en) 2012-04-10
PL370141A1 (en) 2005-05-16
RU2317087C2 (ru) 2008-02-20
EP1474154A2 (en) 2004-11-10
CA2474520A1 (en) 2003-08-21
US20050069583A1 (en) 2005-03-31
CN1315483C (zh) 2007-05-16
KR20040086364A (ko) 2004-10-08
ATE297742T1 (de) 2005-07-15
ZA200405848B (en) 2006-05-31

Similar Documents

Publication Publication Date Title
GB2384986B (en) Compositions for the treatment of disorders of the upper gastrointestinal tract
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
MXPA03008886A (es) Composiciones de baja respuesta glicemica.
EP1567567A4 (en) POLY-HEMA COMPOSITIONS OF LOW POLYDISPERSITY
EP1408064A4 (en) OPEN CHAIN COPOLYMER, HYDROGENATED OPEN CHAIN COPOLYMER, METHODS FOR THEIR PRODUCTION AND COMPOSITIONS
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
GB2386375B (en) Polymer electrolyte composition and uses thereof
MX2008001706A (es) Conjugados de una porcion g-csf y un polimero.
MX249657B (es) Copolimeros elaborados de oxidos de alquileno y glicidil eteres y su uso como emulsionantes polimerizables.
MXPA03003552A (es) Cassette quirurgico.
PL356904A1 (en) Pharmaceutical compositions
HU0200183D0 (en) Carbon dioxide blown low density, flexible microcellular elastomers suitable for preparing shoe component
AU2003261373A1 (en) Alkaline battery including lambda-manganese dioxide
EP1407767A4 (en) AGONIST MEDICINAL PREPARATIONS PPAR $ G (G)
EP1048297A3 (en) Use of polyethylene glycol for reducing of intestinal gas, cramping and anorectal irritation
MXPA03000624A (es) Composiciones y peliculas para la elaboracion de capsulas.
AU2003228205A8 (en) Porous polymers: compositions and uses thereof
AU2003287392A1 (en) Guided capsule for wireless endoscopy, biopsy, and drug delivery
SG111162A1 (en) Novel poly(arylene ether) dielectrics
EP2335646A3 (en) Lip implant
GB0229258D0 (en) Medicinal compositions
PL376926A1 (pl) Nowe analogi 2',5'-oligoadenylanowe
WO2003020265A3 (en) Compositions comprising pectin and ascorbic acid
AU2003206175A1 (en) Block copolymers for surgical articles
WO2006089228A3 (en) Conjugates of an epo moiety and a polymer

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20080212